F.D.A. Panel Approves Lilly Drug for Clotting
Tuesday, February 3, 2009 - 19:49
in Health & Medicine
If the regulators approve the new drug developed by Lilly, it could end the monopoly in the market enjoyed by Bristol-Myers Squibb’s blood thinner, Plavix.
